These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 2960611)

  • 21. Increased expression of interleukin-6 by vasoactive intestinal peptide is associated with regulation of CREB, AP-1 and C/EBP, but not NF-kappaB, in mouse calvarial osteoblasts.
    Persson E; Voznesensky OS; Huang YF; Lerner UH
    Bone; 2005 Oct; 37(4):513-29. PubMed ID: 16085472
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alloreactive cloned T cell lines. VII. Comparison of the kinetics of IL 2 release stimulated by alloantigen or Con A.
    Ely JM; Fitch FW
    J Immunol; 1983 Sep; 131(3):1274-9. PubMed ID: 6604092
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IL 2 production by mitogen-stimulated T cell subsets: helper-precursors are predominantly Lyt-2-.
    Miller RA
    J Immunol; 1983 Dec; 131(6):2864-7. PubMed ID: 6196404
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro induction of a contrasuppressor immunoregulatory network by polyclonally activated T cells derived from murine Peyer's patches.
    Kawanishi H; Kiely J
    Immunology; 1988 Mar; 63(3):415-21. PubMed ID: 2965098
    [TBL] [Abstract][Full Text] [Related]  

  • 25. VIP balances innate and adaptive immune responses induced by specific stimulation of TLR2 and TLR4.
    Arranz A; Juarranz Y; Leceta J; Gomariz RP; Martínez C
    Peptides; 2008 Jun; 29(6):948-56. PubMed ID: 18359536
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vasoactive intestinal peptide generates CD4+CD25+ regulatory T cells in vivo.
    Delgado M; Chorny A; Gonzalez-Rey E; Ganea D
    J Leukoc Biol; 2005 Dec; 78(6):1327-38. PubMed ID: 16204628
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide prevent inducible nitric oxide synthase transcription in macrophages by inhibiting NF-kappa B and IFN regulatory factor 1 activation.
    Delgado M; Munoz-Elias EJ; Gomariz RP; Ganea D
    J Immunol; 1999 Apr; 162(8):4685-96. PubMed ID: 10202009
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dual effect of vasoactive intestinal peptide on the mitogenic response of rabbit spleen lymphocytes.
    Peuriere S; Susini C; Esteve JP; Vaysse N; Escoula L
    Regul Pept; 1990 Jan; 27(1):117-26. PubMed ID: 2155441
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Two different molecular pathways account for low IL-2 receptor and c-myc mRNA expression by lpr Lyt-2- L3T4- T cells.
    Katagiri K; Katagiri T; Yokota S; Eisenberg RA; Cohen PL; Ting JP
    J Immunol; 1988 Sep; 141(6):2145-52. PubMed ID: 3139753
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impaired non-specific suppressor-inducer T-cell activity in aged murine Peyer's patches, which can be corrected largely by IL-2 in vitro.
    Kawanishi H; Kiely J
    Immunology; 1989 Jan; 66(1):61-8. PubMed ID: 15493264
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Functional capacity of T-cell subpopulations of the mouse. Effect of unstimulated and allogenic stimulated T-cell subpopulations on Con A stimulation of splenic lymphocytes].
    Hückel C; Kusnierczyk P; Pajtasz E; Brock J
    Allerg Immunol (Leipz); 1988; 34(1):27-34. PubMed ID: 3261121
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of murine T cell activation by cholera toxin B subunit is not mediated through the phosphatidylinositol second messenger system.
    Woogen SD; Turo K; Dieleman LA; Beagley KW; Elson CO
    J Immunol; 1993 Apr; 150(8 Pt 1):3274-83. PubMed ID: 8468469
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Retrovirus-mediated immunosuppression. II. FeLV-UV alters in vitro murine T lymphocyte behavior by reversibly impairing lymphokine secretion.
    Orosz CG; Zinn NE; Olsen RG; Mathes LE
    J Immunol; 1985 Jul; 135(1):583-90. PubMed ID: 2987350
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of mitogen-induced lymphocyte proliferation by ouabain: interference with interleukin 2 production and interleukin 2 action.
    Stoeck M; Northoff H; Resch K
    J Immunol; 1983 Sep; 131(3):1433-7. PubMed ID: 6604100
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nonspecific inhibitor of DNA synthesis elaborated by T acceptor cells. I. Specific hapten- and I-J-driven liberation of an inhibitor of cell proliferation by Lyt-1-2+ cyclophosphamide-sensitive T acceptor cells armed with a product of Lyt-1+2+-specific suppressor cells.
    Malkovský M; Asherson GL; Chandler P; Colizzi V; Watkins MC; Zembala M
    J Immunol; 1983 Feb; 130(2):785-90. PubMed ID: 6217254
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Age-related defect in signal transduction during lectin activation of murine T lymphocytes.
    Proust JJ; Filburn CR; Harrison SA; Buchholz MA; Nordin AA
    J Immunol; 1987 Sep; 139(5):1472-8. PubMed ID: 3114367
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic treatment of experimental colitis with regulatory dendritic cells generated with vasoactive intestinal peptide.
    Gonzalez-Rey E; Delgado M
    Gastroenterology; 2006 Dec; 131(6):1799-811. PubMed ID: 17087944
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Murine IgA binding factors produced by Fc alpha R(+) T cells: role of Fc gamma R(+) cells for the induction of Fc alpha R and formation of IgA-binding factor in Con A-activated cells.
    Adachi M; Yodoi J; Noro N; Masuda T; Uchino H
    J Immunol; 1984 Jul; 133(1):65-71. PubMed ID: 6233376
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vasoactive intestinal peptide induces CD4+,CD25+ T regulatory cells with therapeutic effect in collagen-induced arthritis.
    Gonzalez-Rey E; Fernandez-Martin A; Chorny A; Delgado M
    Arthritis Rheum; 2006 Mar; 54(3):864-76. PubMed ID: 16508968
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The murine IL 2 receptor. III. Cellular requirements for the induction of IL 2 receptor expression on T cell subpopulations.
    Malek TR; Schmidt JA; Shevach EM
    J Immunol; 1985 Apr; 134(4):2405-13. PubMed ID: 3919092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.